Skip to main content
404 (Not Found)
The website you are looking for is unavailable.
The URL may have been incorrectly typed or the page may have been moved, deleted, or incorporated into another part of the website.

Important Safety Information

What is the most important information I should know about ADAKVEO?

ADAKVEO may cause serious side effects, including infusion-related reactions. 

Infusion-related reactions. Infusion-related reactions may happen during or within 24 hours of receiving an infusion of ADAKVEO. Your health care provider may...

Approved Use

What is ADAKVEO® (crizanlizumab-tmca)?

ADAKVEO is a prescription medicine used in people 16 years of age and older who have sickle cell disease to help reduce how often painful crises happen.

It is not known if ADAKVEO is safe and effective in children under 16 years of age...

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USE